Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Recruiting · NCT06406114 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, anaphylaxis, drug allergy, immune system disorder | Recruiting | Phase 2 | 2026-09-04 | NCT06406114 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| Mayo Clinic Arizona | Scottsdale | United States | 1 |
| Rochester General Hospital | Rochester | United States | 37 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |